{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:15:38Z","timestamp":1777648538458,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018693","name":"H2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bmcl.2024.129690","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T22:00:25Z","timestamp":1709589625000},"page":"129690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes"],"prefix":"10.1016","volume":"103","author":[{"given":"Elli-Anna","family":"Stylianaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varnavas D.","family":"Mouchlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8940-2322","authenticated-orcid":false,"given":"Christiana","family":"Magkrioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos D.","family":"Papavasileiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antreas","family":"Afantitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios N.","family":"Matralis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9531-7729","authenticated-orcid":false,"given":"Vassilis","family":"Aidinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129690_b0005","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis \u2014 A common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2024.129690_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102327","article-title":"Autotaxin and chronic inflammatory diseases","volume":"104","author":"Magkrioti","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.bmcl.2024.129690_b0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.plipres.2015.02.001","article-title":"Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer","volume":"58","author":"Barbayianni","year":"2015","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.bmcl.2024.129690_b0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmed.2018.00180","article-title":"Autotaxin in pathophysiology and pulmonary fibrosis","volume":"5","author":"Ninou","year":"2018","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.bmcl.2024.129690_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","article-title":"Regulation and biological activities of the autotaxin-LPA axis","volume":"46","author":"van Meeteren","year":"2007","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.bmcl.2024.129690_b0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2008.06.005","article-title":"Two pathways for lysophosphatidic acid production","volume":"1781","author":"Aoki","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmcl.2024.129690_b0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2012-0004OC","article-title":"Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis","volume":"47","author":"Oikonomou","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bmcl.2024.129690_b0040","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","article-title":"Hepatocyte autotaxin expression promotes liver fibrosis and cancer","volume":"65","author":"Kaffe","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bmcl.2024.129690_b0045","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/art.39797","article-title":"An autotaxin\/lysophosphatidic acid\/Interleukin-6 amplification loop drives scleroderma fibrosis","volume":"68","author":"Castelino","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.bmcl.2024.129690_b0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.20112012","article-title":"Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis","volume":"209","author":"Nikitopoulou","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmcl.2024.129690_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143083","article-title":"The bulk of autotaxin activity is dispensable for adult mouse life","volume":"10","author":"Katsifa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2024.129690_b0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nsmb.1998","article-title":"Crystal structure of autotaxin and insight into GPCR activation by lipid mediators","volume":"18","author":"Nishimasu","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmcl.2024.129690_b0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nsmb.1980","article-title":"Structural basis of substrate discrimination and integrin binding by autotaxin","volume":"18","author":"Hausmann","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmcl.2024.129690_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101577","article-title":"The structural binding mode of the four autotaxin inhibitor types that differentially affect catalytic and non-catalytic functions","volume":"11","author":"Salgado-Polo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmcl.2024.129690_b0075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/med.21551","article-title":"Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials","volume":"39","author":"Matralis","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2024.129690_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197002","article-title":"Structure-based discovery of novel chemical classes of autotaxin inhibitors","volume":"21","author":"Magkrioti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2024.129690_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115130","article-title":"\u201cHit\u201d to lead optimization and chemoinformatic studies for a new series of Autotaxin inhibitors","volume":"249","author":"Stylianaki","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129690_b0090","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1021\/acs.jmedchem.2c00368","article-title":"Structure-based design of a novel class of autotaxin inhibitors based on endogenous allosteric modulators","volume":"65","author":"Clark","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129690_b0095","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/jama.2023.5355","article-title":"Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials","volume":"329","author":"Maher","year":"2023","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bmcl.2024.129690_b0100","article-title":"Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors","volume":"18","author":"Deken","year":"2023","journal-title":"Immuno-Oncol Technol"},{"key":"10.1016\/j.bmcl.2024.129690_b0105","unstructured":"iOnctura, C.r.h. iOnctura initiates Phase Ib pancreatic cancer trial of next-generation autotaxin inhibitor IOA-289. 2022; Available from: https:\/\/www.cancerresearchhorizons.com\/news\/ionctura-initiates-phase-ib-pancreatic-cancer-trial-next-generation-autotaxin-inhibitor-ioa."},{"key":"10.1016\/j.bmcl.2024.129690_b0110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acsmedchemlett.6b00207","article-title":"Novel autotaxin inhibitors for the treatment of osteoarthritis pain: Lead optimization via structure-based drug design","volume":"7","author":"Jones","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129690_b0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/mol.115.100404","article-title":"Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding","volume":"88","author":"Stein","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129690_b0120","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1021\/acs.jmedchem.7b00032","volume":"60","author":"Desroy","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129690_b0125","doi-asserted-by":"crossref","unstructured":"Meng EC, et al., UCSF ChimeraX: Tools for structure building and analysis. Protein Sci. n\/a(n\/a): e4792. https:\/\/doi.org\/10.1002\/pro.4792.","DOI":"10.1002\/pro.4792"},{"key":"10.1016\/j.bmcl.2024.129690_b0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmcl.2024.129690_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmcl.2024.129690_b0140","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/bioinformatics\/btl150","article-title":"Molecular complexes at a glance: automated generation of two-dimensional complex diagrams","volume":"22","author":"Stierand","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bmcl.2024.129690_b0145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1021\/ci049958u","article-title":"Automated drawing of structural molecular formulas under constraints","volume":"44","author":"Fricker","year":"2004","journal-title":"J Chem Inf Comput Sci"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:49:30Z","timestamp":1760773770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":29,"alternative-id":["S0960894X24000921"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129690","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129690"}}